Palisade Bio (PALI) Cash from Operations (2010 - 2026)
Palisade Bio (PALI) reported Cash from Operations of 3890000.0 for Q1 2026, down 66.74% year-over-year from 11695064.43 in Q1 2025, and down 23.73% on a QoQ basis from 3144000.0 in Q4 2025.
Palisade Bio (PALI) has 17 years of Cash from Operations data on file, last reported at 3890000.0 in Q1 2026.
- Quarterly Cash from Operations fell 66.74% year-over-year to 3890000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12404000.0 (down 9.32% YoY) and the FY2025 annual result came in at 10847000.0, up 11.04% from the prior year.
- Cash from Operations slipped to 3890000.0 in Q1 2026 per PALI's latest filing, from 3144000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1817000.0 in Q2 2025 and bottomed at 3890000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 3144000.0 (2025), against an average of 3024882.35.
- Peak annual rise in Cash from Operations reached 57.91% in 2022, while the deepest fall reached 201.12% in 2022.
- Tracing PALI's Cash from Operations over 5 years: stood at 3306000.0 in 2022, then gained by 16.94% to 2746000.0 in 2023, then advanced by 13.29% to 2381000.0 in 2024, then plunged by 32.05% to 3144000.0 in 2025, then retreated by 23.73% to 3890000.0 in 2026.
- Per Business Quant, the three latest PALI Cash from Operations figures stand at 3890000.0 (Q1 2026), 3144000.0 (Q4 2025), and 3553000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Sep 30, 2023 | -2.66 Mn |
| Sep 30, 2023 | -2.66 Mn |
| Jun 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | -2.20 Mn |
| Mar 31, 2023 | -3.53 Mn |
| Mar 31, 2023 | -3.53 Mn |
| Dec 31, 2022 | -3.31 Mn |
| Dec 31, 2022 | -3.31 Mn |
| Sep 30, 2022 | -3.04 Mn |
| Sep 30, 2022 | -3.04 Mn |
| Jun 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | -3.25 Mn |
| Mar 31, 2022 | -3.76 Mn |
| Mar 31, 2022 | -3.76 Mn |
| Dec 31, 2021 | -3.06 Mn |
| Dec 31, 2021 | -3.06 Mn |
| Sep 30, 2021 | -2.75 Mn |
| Sep 30, 2021 | -2.75 Mn |
| Jun 30, 2021 | -7.72 Mn |
| Jun 30, 2021 | -7.72 Mn |
| Mar 31, 2021 | -1.25 Mn |
| Mar 31, 2021 | -1.25 Mn |
| Dec 31, 2020 | -1.55 Mn |
| Dec 31, 2020 | -1.55 Mn |
| Sep 30, 2020 | -869,000.00 |
| Sep 30, 2020 | -869,000.00 |
| Jun 30, 2020 | -673,371.00 |
| Jun 30, 2020 | -673,371.00 |
| Mar 31, 2020 | -1.68 Mn |
| Mar 31, 2020 | -1.68 Mn |
| Dec 31, 2019 | -2.05 Mn |
| Dec 31, 2019 | -2.05 Mn |
| Sep 30, 2019 | -1.90 Mn |
| Sep 30, 2019 | -1.90 Mn |
| Jun 30, 2019 | -1.64 Mn |
| Jun 30, 2019 | -1.64 Mn |
| Mar 31, 2019 | -1.67 Mn |
| Mar 31, 2019 | -1.67 Mn |
| Dec 31, 2018 | -1.66 Mn |
| Dec 31, 2018 | -1.66 Mn |
| Sep 30, 2018 | -1.66 Mn |
| Sep 30, 2018 | -1.66 Mn |
| Jun 30, 2018 | -2.52 Mn |
| Jun 30, 2018 | -2.52 Mn |
| Mar 31, 2018 | -1.85 Mn |
| Mar 31, 2018 | -1.85 Mn |
| Dec 31, 2017 | -2.29 Mn |
| Dec 31, 2017 | -2.29 Mn |
| Sep 30, 2017 | -3.32 Mn |
| Sep 30, 2017 | -3.32 Mn |
| Jun 30, 2017 | -3.37 Mn |
| Jun 30, 2017 | -3.37 Mn |
| Mar 31, 2017 | -4.44 Mn |
| Mar 31, 2017 | -4.44 Mn |
| Dec 31, 2016 | -4.08 Mn |
| Dec 31, 2016 | -4.08 Mn |
| Sep 30, 2016 | -4.48 Mn |
| Sep 30, 2016 | -4.48 Mn |
| Jun 30, 2016 | -3.57 Mn |
| Jun 30, 2016 | -3.57 Mn |
| Mar 31, 2016 | -3.49 Mn |
| Mar 31, 2016 | -3.49 Mn |
| Dec 31, 2015 | -3.90 Mn |
| Dec 31, 2015 | -3.90 Mn |
| Sep 30, 2015 | -5.51 Mn |
| Sep 30, 2015 | -5.51 Mn |
| Jun 30, 2015 | -4.80 Mn |
| Jun 30, 2015 | -4.80 Mn |
| Mar 31, 2015 | -4.72 Mn |
| Mar 31, 2015 | -4.72 Mn |
| Dec 31, 2014 | -3.48 Mn |
| Dec 31, 2014 | -3.48 Mn |
| Sep 30, 2014 | -3.10 Mn |
| Sep 30, 2014 | -3.10 Mn |
| Jun 30, 2014 | -2.41 Mn |
| Jun 30, 2014 | -2.41 Mn |
| Mar 31, 2014 | -2.71 Mn |
| Mar 31, 2014 | -2.71 Mn |
| Dec 31, 2013 | -2.48 Mn |
| Dec 31, 2013 | -2.48 Mn |
| Sep 30, 2013 | -2.24 Mn |
| Sep 30, 2013 | -2.24 Mn |
| Jun 30, 2013 | -3.36 Mn |
| Jun 30, 2013 | -3.36 Mn |
| Mar 31, 2013 | -2.51 Mn |
| Mar 31, 2013 | -2.51 Mn |
| Dec 31, 2012 | -2.52 Mn |
| Dec 31, 2012 | -2.52 Mn |
| Sep 30, 2012 | -1.42 Mn |
| Sep 30, 2012 | -1.42 Mn |
| Jun 30, 2012 | -2.44 Mn |
| Jun 30, 2012 | -2.44 Mn |
| Mar 31, 2012 | -2.10 Mn |
| Mar 31, 2012 | -2.10 Mn |
| Dec 31, 2011 | -1.78 Mn |
| Dec 31, 2011 | -1.78 Mn |
| Sep 30, 2011 | -1.81 Mn |
| Sep 30, 2011 | -1.81 Mn |
| Jun 30, 2011 | -2.21 Mn |
| Jun 30, 2011 | -2.21 Mn |
| Mar 31, 2011 | -2.29 Mn |
| Mar 31, 2011 | -2.29 Mn |
| Dec 31, 2010 | -2.75 Mn |
| Dec 31, 2010 | -2.75 Mn |
| Sep 30, 2010 | -2.35 Mn |
| Sep 30, 2010 | -2.35 Mn |